(13:01 GMT) EyePoint Pharmaceuticals Price Target Raised to $65.00/Share From $29.00 by Chardan Capital
Dow Jones Newswires
EyePoint Pharmaceuticals Is Maintained at Buy by Chardan Capital
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:EYPT
- Language
- English